EASYMERS
LIVE

Serial Number

79312359

Owner

immunAware ApS

Attorney

Mark Wright

Filing Date

Feb 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EASYMERS Trademark

Serial Number: 79312359 • Registration: 6776851

EASYMERS is a trademark filed by immunAware ApS on February 11, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

immunAware ApS

Agern Alle 1

Entity Type: 66

Trademark Details

Filing Date

February 11, 2021

Registration Date

July 5, 2022

Published for Opposition

April 19, 2022

Goods & Services

Reagents for immunoanalysis for medical use; preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations for pharmaceutical or medical purposes; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; biochemical analysis preparations for medical purposes and the aforementioned preparations all for development and analysis of vaccines, immunotherapy and cellular therapy, namely, cancer vaccines and cancer immunotherapy, and T cell therapies; biochemical analysis preparations for pharmaceutical or medical purposes for use in cancer therapy or other therapy, for the analysis of T cell infiltration of solid tumors and tissue, as well as infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T cell monitoring, all for medical or veterinary purposes

Reagents for scientific and research use, namely, reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes, namely, Diagnostic reagents and preparations, except for medical or veterinary use, Chemicals for use in industry and science, Chemical preparations for general industrial manufacturing; diagnostic reagents for scientific diagnostic not for medical and veterinary purposes; research reagents for scientific and diagnostic research purposes; diagnostic test materials for scientific and diagnostic purposes not for medical or veterinary purposes, namely, Diagnostic preparations, other than for medical or veterinary purposes, Diagnostic reagents for scientific or research use, Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemical reagents used for non-medical purposes; chemical reagents, other than for medical or veterinary purposes; biochemical diagnostic kits for scientific and diagnostic purposes not for medical or veterinary purposes comprised of biochemical reagents used for non-medical purposes; biochemical analysis kits for research and diagnostic purposes not for medical and veterinary purposes comprised of biochemicals for in vitro and in vivo scientific use; biochemical analysis preparations for scientific purposes related to vaccines and immunotherapy, including cancer therapy, cancer immunotherapy, analysis or treatment of cancer, infectious diseases and/or autoimmunity, and for use in connection with toxicological studies, transplantation, and immune monitoring and T cell monitoring

Scientific and technological analyses of T cells and their responses, namely, research services and design of T cells and their responses; industrial analysis of T cells and their responses, including for development of medicines and vaccines; basic scientific and clinical research on T cells and their responses, including for the development of medicines and vaccines

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 7, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Oct 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 5, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 3, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
ASSIGNED TO LIE
Mar 14, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 10, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 27, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 27, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 11, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 3, 2021 REPR